Your browser is no longer supported. Please, upgrade your browser.
GENE Genetic Technologies Limited daily Stock Chart
Genetic Technologies Limited
Index- P/E- EPS (ttm)-1.00 Insider Own86.50% Shs Outstand5.98M Perf Week25.43%
Market Cap12.98M Forward P/E- EPS next Y- Insider Trans- Shs Float5.98M Perf Month8.22%
Income-4.40M PEG- EPS next Q- Inst Own2.80% Short Float0.20% Perf Quarter-12.50%
Sales- P/S- EPS this Y-8.90% Inst Trans-4.01% Short Ratio0.15 Perf Half Y-30.89%
Book/sh0.27 P/B8.04 EPS next Y- ROA-116.30% Target Price12.50 Perf Year-54.41%
Cash/sh0.25 P/C8.65 EPS next 5Y- ROE-152.70% 52W Range1.56 - 6.32 Perf YTD-0.75%
Dividend- P/FCF- EPS past 5Y49.00% ROI- 52W High-65.66% Beta3.68
Dividend %- Quick Ratio2.10 Sales past 5Y- Gross Margin- 52W Low39.09% ATR0.21
Employees64 Current Ratio2.10 Sales Q/Q-92.30% Oper. Margin- RSI (14)56.19 Volatility14.86% 10.96%
OptionableYes Debt/Eq0.00 EPS Q/Q82.90% Profit Margin- Rel Volume0.27 Prev Close2.29
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume76.79K Price2.17
Recom- SMA2010.79% SMA507.96% SMA200-22.57% Volume20,663 Change-5.24%
May-22-19 03:11PM  Genetic Technologies Announces Offering of Approximately USD 1.2 Million of American Depository Shares GlobeNewswire -33.33%
May-17-19 01:30PM  Genetic Technologies Interview to Air on Bloomberg International on the RedChip Money Report GlobeNewswire
May-10-19 08:10AM  Genetic Technologies Limited (ASX Code: GTG; NASDAQ Ticker: GENE) announces successful completion of two new ground-breaking Genetic Risk Tests for Colorectal Cancer and for Breast Cancer GlobeNewswire +95.31%
May-03-19 08:45AM  Genetic Technologies Receives Nasdaq Notification Letter GlobeNewswire
Apr-15-19 09:00AM  Genetic Technologies and The Translational Genomics Research Institute of Phoenix, Arizona Sign Memorandum of Understanding GlobeNewswire
Apr-11-19 09:15AM  Genetic Technologies Asian Operations Established in Hainan, China GlobeNewswire
Feb-01-19 05:30AM  Genetic Technologies Limited Announces Research Collaboration with Two World-Renowned Medical Centres GlobeNewswire
Dec-21-18 05:30AM  Genetic Technologies Limited Provides End of Year Update on the Test Development Program GlobeNewswire +18.48%
Dec-20-18 06:04PM  Genetic Technologies Limited Announces New Biomedical Blockchain Joint Venture GlobeNewswire -13.22%
Sep-17-18 05:30AM  Genetic Technologies Invited to Establish a Market Presence in Hainan, China GlobeNewswire
Aug-21-18 05:30AM  Genetic Technologies Limited Invited by Representatives of the Hainan Government to Discuss Market Entry into China GlobeNewswire +8.11%
Aug-16-18 05:30AM  Genetic Technologies Announces Proposed Joint Venture with Beijing Zishan Health Consultancy Limited GlobeNewswire +5.61%
Aug-08-18 05:30AM  Genetic Technologies Secures A$20 Million Equity Placement Facility GlobeNewswire
Aug-02-18 06:00AM  Genetic Technologies Formalises Strategic Alliance with Blockchain Global GlobeNewswire
Jul-30-18 06:00AM  Genetic Technologies Announces Appointment of Swisstec as Non-Exclusive Asian Distributor GlobeNewswire
Jul-17-18 08:10AM  Todays Research Reports on Stocks to Watch: Genetic Technologies and Innovate Biopharmaceuticals ACCESSWIRE -10.14%
Jul-16-18 09:26AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga +35.78%
05:30AM  Genetic Technologies Limited Announces Expansion of Genetic Risk Assessment Tests and October Launch of New Breast Cancer and Colorectal Cancer Tests GlobeNewswire
Jun-19-18 05:30AM  Genetic Technologies Announces Heads of Agreement with Swisstec GlobeNewswire
Jun-07-18 05:30AM  Genetic Technologies Announces Binding Project Shivom Agreement GlobeNewswire
May-30-18 06:00AM  Why KISS Rocker Gene Simmons Sees Dow 30,000 Investopedia
May-01-18 05:30AM  Genetic Technologies Announces Grant from NHMRC Awarded to University of Melbourne to Substantially Improve Breast Cancer Risk Prediction and Increase Accessibility GlobeNewswire
Mar-20-18 11:13AM  Invictus MD Strategies Corp. Opens the Market PR Newswire
11:13AM  Invictus MD Strategies Corp. Opens the Market CNW Group
Mar-16-18 05:00AM  Genetic Technologies Limited Announces Further Collaborative Research with The University of Melbourne to Broaden the Applicability of the BREVAGenplus® Breast Cancer Risk Assessment Test GlobeNewswire
Mar-06-18 09:14AM  Shivom Partnership With Genetic Technologies Will Enable Better Cancer Prediction and Prevention Through Mass Genomic Data Analysis PR Newswire +20.33%
05:30AM  Genetic Technologies Limited: Project Shivom Strategic Alliance GlobeNewswire
Feb-15-18 05:00AM  Genetic Technologies Announces Strategic Alliance and Capital Raising GlobeNewswire -14.05%
Feb-12-18 05:00AM  Genetic Technologies Limited: Update on Strategic Alliance GlobeNewswire
Feb-06-18 05:00AM  Change of Chief Executive Officer GlobeNewswire
Feb-05-18 05:00AM  Appointment of Chairman GlobeNewswire
Jan-31-18 05:00AM  Results from 31 January 2018 General Meeting GlobeNewswire
Jan-30-18 05:00AM  Resignation of Directors GlobeNewswire
Jan-29-18 05:30AM  Genetic Technologies Limited: Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 31 December 2017 GlobeNewswire
Jan-09-18 09:11AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga +15.22%
Oct-05-17 08:10AM  Today's Research Reports on Stocks to Watch: Tetraphase Pharmaceuticals and Genetic Technologies ACCESSWIRE
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage the women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. The company has a research and service agreement with The University of Melbourne for the development and enhancement of the BREVAGenplus breast cancer risk assessment test, as well as a strategic alliance with Blockchain Global Limited. Genetic Technologies Limited was founded in 1989 and is headquartered in Fitzroy, Australia.